Haleon PLC (HLN)
Haleon Market Cap: 38.22B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 38.22B |
May 15, 2024 | 38.40B |
May 14, 2024 | 37.99B |
May 13, 2024 | 37.67B |
May 10, 2024 | 37.63B |
May 09, 2024 | 37.72B |
May 08, 2024 | 37.40B |
May 07, 2024 | 38.04B |
May 06, 2024 | 37.63B |
May 03, 2024 | 37.90B |
May 02, 2024 | 37.99B |
May 01, 2024 | 38.13B |
April 30, 2024 | 38.95B |
April 29, 2024 | 38.68B |
April 26, 2024 | 38.58B |
April 25, 2024 | 38.36B |
April 24, 2024 | 38.13B |
April 23, 2024 | 38.40B |
April 22, 2024 | 38.17B |
April 19, 2024 | 37.53B |
April 18, 2024 | 37.12B |
April 17, 2024 | 37.03B |
April 16, 2024 | 36.99B |
April 15, 2024 | 36.80B |
April 12, 2024 | 36.57B |
Date | Value |
---|---|
April 11, 2024 | 37.31B |
April 10, 2024 | 37.31B |
April 09, 2024 | 37.85B |
April 08, 2024 | 37.53B |
April 05, 2024 | 37.85B |
April 04, 2024 | 37.58B |
April 03, 2024 | 37.63B |
April 02, 2024 | 37.81B |
April 01, 2024 | 38.08B |
March 28, 2024 | 38.77B |
March 27, 2024 | 38.95B |
March 26, 2024 | 38.40B |
March 25, 2024 | 38.49B |
March 22, 2024 | 38.26B |
March 21, 2024 | 38.04B |
March 20, 2024 | 38.05B |
March 19, 2024 | 38.69B |
March 18, 2024 | 37.49B |
March 15, 2024 | 38.37B |
March 14, 2024 | 38.00B |
March 13, 2024 | 39.66B |
March 12, 2024 | 39.99B |
March 11, 2024 | 39.52B |
March 08, 2024 | 39.85B |
March 07, 2024 | 39.48B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Pfizer Inc | 163.88B |
GSK PLC | 91.51B |
AstraZeneca PLC | 238.86B |
Verona Pharma PLC | 1.083B |
Adaptimmune Therapeutics PLC | 296.19M |
Market Cap Related Metrics
PE Ratio | 28.19 |
PS Ratio | 2.736 |
PEG Ratio | 8.958 |
Price to Book Value | 1.807 |
Price | 8.37 |
Earnings Yield | 3.55% |
PEGY Ratio | 5.675 |
Operating PE Ratio | 15.16 |
Normalized PE Ratio | 28.39 |